title: Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy.
abstract: Both severe impairments of brain development in untreated infants and acute reversible neurotoxic effects on brain function are clinical features of phenylketonuria (PKU). For determining whether impairments of cerebral energy metabolism play a role in the pathophysiology of PKU, quantitative in vivo 31P magnetic resonance spectroscopy (MRS) was performed in a supratentorial voxel of 11 adult PKU patients and controls. Peak areas of inorganic phosphate; phosphocreatine; alpha-, beta-, and gamma-ATP; NAD; phosphomonoesters; phosphodiesters; and a broad phospholipid signal were converted to millimolar concentrations. Mg2+, pH, ADP, the phosphorylation potential, and the relative velocity of oxidative metabolism V/Vmax were derived. Clinical evaluation included mutation analysis, neurologic investigation, intelligence testing, magnetic resonance imaging, and concurrent plasma and brain phenylalanine (Phe), the last by 1H-MRS. Phe loading was performed in five patients with an oral dose of 100 mg/kg body wt L-Phe monitored by spectral EEG analysis. Under steady-state conditions, 31P-MRS revealed normal values for ATP, phosphocreatine, NAD, phosphomonoesters, phosphodiesters, Mg2+, and pH in PKU. ADP (+11%) and the phosphorylation potential (+22%) were increased. Peak areas of inorganic phosphate (-22%) and phospholipid (-8%) were decreased. ADP correlated with concurrent plasma (r = 0.65) and brain (r = 0.55) Phe. During the Phe load, blood Phe levels increased steeply. EEG revealed slowing of background activity. The phosphorylation potential decreased, whereas ADP and V/Vmax increased. In vivo 31P-MRS demonstrated subtle abnormalities of cerebral energy metabolism in PKU in steady-state conditions that were accentuated by a Phe load, indicating a link between Phe neurotoxicity and imbalances of cerebral energy metabolism.
authors.affiliation: Department of Pediatric Neurology, Division of Metabolic and Endocrine Diseases, University of Heidelberg, Im Neuenheimer Feld 150, Germany. joachim_pietz@med.uni-heidelberg.de
authors.forename: Joachim
authors.initials: J
authors.lastname: Pietz
authors.forename: André
authors.initials: A
authors.lastname: Rupp
authors.forename: Friedrich
authors.initials: F
authors.lastname: Ebinger
authors.forename: Dietz
authors.initials: D
authors.lastname: Rating
authors.forename: Ertan
authors.initials: E
authors.lastname: Mayatepek
authors.forename: Chris
authors.initials: C
authors.lastname: Boesch
authors.forename: Roland
authors.initials: R
authors.lastname: Kreis
mesh_terms: D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D004569:Electroencephalography; D004734:Energy Metabolism / Q000502:physiology*; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010649:Phenylalanine; D010661:Phenylketonurias / Q000000981:diagnostic imaging* / Q000378:metabolism*; D010759:Phosphorus Isotopes; D011877:Radionuclide Imaging
chemical_list: D010759:Phosphorus Isotopes; D010649:Phenylalanine